LUR
{2-[(2-chloro-6-fluorophenyl)amino]-5-methylphenyl}acetic acid
Created: | 2012-12-26 |
Last modified: | 2021-03-01 |
Find Related PDB Entry |
---|
Find related ligands: |
---|
Chemical Details | |
---|---|
Formal Charge | 0 |
Atom Count | 33 |
Chiral Atom Count | 0 |
Bond Count | 34 |
Aromatic Bond Count | 12 |
Chemical Component Summary | |
---|---|
Name | {2-[(2-chloro-6-fluorophenyl)amino]-5-methylphenyl}acetic acid |
Synonyms | Lumiracoxib |
Systematic Name (OpenEye OEToolkits) | 2-[2-[(2-chloranyl-6-fluoranyl-phenyl)amino]-5-methyl-phenyl]ethanoic acid |
Formula | C15 H13 Cl F N O2 |
Molecular Weight | 293.721 |
Type | NON-POLYMER |
Chemical Descriptors | |||
---|---|---|---|
Type | Program | Version | Descriptor |
SMILES | ACDLabs | 12.01 | Clc2cccc(F)c2Nc1ccc(cc1CC(=O)O)C |
SMILES | CACTVS | 3.370 | Cc1ccc(Nc2c(F)cccc2Cl)c(CC(O)=O)c1 |
SMILES | OpenEye OEToolkits | 1.7.6 | Cc1ccc(c(c1)CC(=O)O)Nc2c(cccc2Cl)F |
Canonical SMILES | CACTVS | 3.370 | Cc1ccc(Nc2c(F)cccc2Cl)c(CC(O)=O)c1 |
Canonical SMILES | OpenEye OEToolkits | 1.7.6 | Cc1ccc(c(c1)CC(=O)O)Nc2c(cccc2Cl)F |
InChI | InChI | 1.03 | InChI=1S/C15H13ClFNO2/c1-9-5-6-13(10(7-9)8-14(19)20)18-15-11(16)3-2-4-12(15)17/h2-7,18H,8H2,1H3,(H,19,20) |
InChIKey | InChI | 1.03 | KHPKQFYUPIUARC-UHFFFAOYSA-N |
Drug Info: DrugBank
DrugBank ID | DB01283 |
---|---|
Name | Lumiracoxib |
Groups |
|
Description | Lumiracoxib is a COX-2 selective non-steroidal anti-inflammatory drug (NSAID). On August 11, 2007, Australia's Therapeutic Goods Administration (TGA, the Australian equivalent of the FDA) cancelled the registration of lumiracoxib in Australia due to concerns that it may cause liver failure. New Zealand and Canada have also followed suit in recalling the drug. |
Synonyms |
|
Indication | For the acute and chronic treatment of the signs and symptoms of osteoarthritis of the knee in adults. |
Categories |
|
ATC-Code | M01AH06 |
CAS number | 220991-20-8 |
Drug Targets
Name | Target Sequence | Pharmacological Action | Actions |
---|---|---|---|
Prostaglandin G/H synthase 2 | MLARALLLCAVLALSHTANPCCSHPCQNRGVCMSVGFDQYKCDCTRTGFY... | unknown | inhibitor |
Prostaglandin G/H synthase 1 | MSRSLLLWFLLFLLLLPPLPVLLADPGAPTPVNPCCYYPCQHQGICVRFG... | unknown | inhibitor |
Cytochrome P450 2C19 | MDPFVVLVLCLSCLLLLSIWRQSSGRGKLPPGPTPLPVIGNILQIDIKDV... | unknown | substrate |
UDP-glucuronosyltransferase 1A9 | MACTGWTSPLPLCVCLLLTCGFAEAGKLLVVPMDGSHWFTMRSVVEKLIL... | unknown | substrate |
Cytochrome P450 1A2 | MALSQSVPFSATELLLASAIFCLVFWVLKGLRPRVPKGLKSPPEPWGWPL... | unknown | substrate |
View More |
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison
T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS.
Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682
Related Resource References
Resource Name | Reference |
---|---|
Pharos | CHEMBL404108 |
PubChem | 151166 |
ChEMBL | CHEMBL404108 |
ChEBI | CHEBI:73044 |